WealthPLAN Partners, LLC - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 45 filers reported holding GALECTIN THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WealthPLAN Partners, LLC ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q1 2017$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q3 2016$2,775,000
-24.6%
2,500
-50.0%
0.00%
Q2 2016$3,679,000
-10.4%
5,000
-33.3%
0.00%
-100.0%
Q4 2015$4,108,000
+58585.7%
7,500
+200.0%
0.00%
-66.7%
Q2 2015$7,000
-12.5%
2,5000.0%0.00%
-25.0%
Q1 2015$8,0002,5000.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 129,488$271,9250.08%
Geneos Wealth Management Inc. 427,400$897,5400.06%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$25,2000.02%
Vivaldi Capital Management LP 19,261$40,4480.01%
Beacon Capital Management, LLC 12,605$26,4710.01%
Atria Wealth Solutions, Inc. 263,300$552,9300.01%
Wealthspire Advisors, LLC 183,862$386,1110.01%
BARRETT & COMPANY, INC. 4,984$10,4660.01%
OSAIC HOLDINGS, INC. 1,271,760$2,670,6560.01%
Ameritas Advisory Services, LLC 45,302$94,8560.01%
View complete list of GALECTIN THERAPEUTICS INC shareholders